Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a clinical research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical device testing, patient recruitment, clinical evaluation and development, data management, biostatistics and statistical programming services. The company also provides integrated technology services including site management, pharmacovigilance, third-party audit and training, medical imaging and clinical trial system solutions. Tigermed conducts research in the therapeutic areas of oncology, infections, hematology, cardiovascular, endocrinology, rheumatology, nephrology and gastroenterology. It serves pharmaceutical and biotechnology companies. Hangzhou Tigermed is headquartered in Hangzhou, Zhejiang, China.
Headquarters
China
Address
18th Floor, Building A – Shengda Science Park, No.19 Jugong Road, Hangzhou, Zhejiang, 310051
Website
www.tigermedgrp.com
Telephone
86 571 28887227
No of Employees
9,701
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
300347 (SHE)
Revenue (2022)
$1.0B
4.2%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
0.9%
(2022 vs 2021)
Market Cap*
$5.6B
Net Profit Margin (2022)
XYZ
-3.2%
(2022 vs 2021)
* As of and is in US$
Hangzhou Tigermed Consulting Co Ltd premium industry data and analytics
Products and Services
| Services |
|---|
| Regulatory Affairs: |
| Regulatory Submission and Approval |
| Medical Translation |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Corporate Changes/Expansions | In August, the company opened international headquarters in Hong Kong. |
| 2023 | Acquisitions/Mergers/Takeovers | In January, the company announced the acquisition of Marti Farm. |
| 2019 | Contracts/Agreements | In November, the company and Accerise Inc., announced to establish a joint venture to provide international multicenter clinical trial services in Japan. |
Competitor Comparison
| Key Parameters | Hangzhou Tigermed Consulting Co Ltd | Harbin Gloria Pharmaceuticals Co Ltd | Hybio Pharmaceutical Co Ltd | Guangzhou Boji Medical & Biotechnological Co Ltd | BravoVax Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Hangzhou | Beijing | Shenzhen | Guangzhou | Wuhan |
| State/Province | Zhejiang | Beijing | Guangdong | Guangdong | Hubei |
| No. of Employees | 9,701 | 3,507 | 975 | 1,186 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ye Xiaoping, Ph.D. | Chairman; Co Founder | Executive Board | 2010 | 60 |
| Zengyu Wen | Executive Vice President; Chief Operating Officer; Director | Executive Board | 2023 | 43 |
| Xiaochun Cao | Co Founder; General Manager; Director | Executive Board | 2019 | 54 |
| Hao Wu | Director; Co President | Executive Board | 2021 | 56 |
| Chengcheng Yang | Chief Financial Officer | Senior Management | 2022 | 49 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward